Literature DB >> 27000298

High prevalence of Mycobacterium tuberculosis bacteraemia among a cohort of HIV-infected patients with severe sepsis in Lusaka, Zambia.

Levy Muchemwa1, Lakhi Shabir2, Ben Andrews3, Mwango Bwalya4.   

Abstract

Tuberculosis is recognised as one of the leading causes of severe sepsis among HIV-infected patients. Most patients with Mycobacterium tuberculosis bacteraemia have advanced HIV disease with CD4 counts less than 100 cells/μl and its presentation is non-specific in most instances. This was a cross-sectional study which was done by analyzing data from 201 adult HIV-infected patients who met the inclusion criteria for severe sepsis. The prevalence of Mycobacterium tuberculosis bactraemia in the study population was 34.8%. Severe sepsis caused by other etiologies was observed in 33 (16.4%) of the participants. Concomitant infection of Mycobacterium tuberculosis bactraemia with other organisms is not uncommon in patients with severe sepsis. This cohort of HIV-infected patients had severe immunosuppression with a median CD4 count of 51 (20-136) cells/μl with moderate anaemia, mean haemoglobin 8.0 (3.0) g/dl, and were generally underweight with a mean mid upper arm circumference (MUAC) of 21.0 (3.4) cm. Mycobacterium tuberculosis bacteraemia is very common in HIV-infected patients with advanced HIV disease who present with severe sepsis. Mycobacterium tuberculosis bacteraemia co-infection with aerobic organisms is not uncommon. Factors that were independently associated with Mycobacterium tuberculosis bacteraemia in our study population were MUAC and sodium level.

Entities:  

Keywords:  AIDS; highly active antiretroviral therapy; human immunodeficiency virus

Mesh:

Year:  2016        PMID: 27000298     DOI: 10.1177/0956462416640963

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  6 in total

Review 1.  The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management.

Authors:  M J Maze; Q Bassat; N A Feasey; I Mandomando; P Musicha; J A Crump
Journal:  Clin Microbiol Infect       Date:  2018-02-15       Impact factor: 8.067

2.  Effect of Empiric Anti-Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus-Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda.

Authors:  Riley H Hazard; Peninah Kagina; Richard Kitayimbwa; Keneth Male; Melissa McShane; Dennis Mubiru; Emma Welikhe; Christopher C Moore; Amir Abdallah
Journal:  Open Forum Infect Dis       Date:  2019-03-14       Impact factor: 3.835

3.  Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.

Authors:  Charlotte Schutz; David Barr; Bruno B Andrade; Muki Shey; Amy Ward; Saskia Janssen; Rosie Burton; Katalin A Wilkinson; Bianca Sossen; Kiyoshi F Fukutani; Mark Nicol; Gary Maartens; Robert J Wilkinson; Graeme Meintjes
Journal:  PLoS Med       Date:  2019-07-05       Impact factor: 11.069

4.  Aetiology and outcomes of sepsis in adults in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Joseph M Lewis; Nicholas A Feasey; Jamie Rylance
Journal:  Crit Care       Date:  2019-06-11       Impact factor: 9.097

5.  Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.

Authors:  David A Barr; Joseph M Lewis; Nicholas Feasey; Charlotte Schutz; Andrew D Kerkhoff; Shevin T Jacob; Ben Andrews; Paul Kelly; Shabir Lakhi; Levy Muchemwa; Helio A Bacha; David J Hadad; Richard Bedell; Monique van Lettow; Rony Zachariah; John A Crump; David Alland; Elizabeth L Corbett; Krishnamoorthy Gopinath; Sarman Singh; Rulan Griesel; Gary Maartens; Marc Mendelson; Amy M Ward; Christopher M Parry; Elizabeth A Talbot; Patricia Munseri; Susan E Dorman; Neil Martinson; Maunank Shah; Kevin Cain; Charles M Heilig; Jay K Varma; Anne von Gottberg; Leonard Sacks; Douglas Wilson; S Bertel Squire; David G Lalloo; Gerry Davies; Graeme Meintjes
Journal:  Lancet Infect Dis       Date:  2020-03-13       Impact factor: 25.071

6.  Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosis.

Authors:  Charlotte Schutz; Maxwell Chirehwa; David Barr; Amy Ward; Saskia Janssen; Rosie Burton; Robert J Wilkinson; Muki Shey; Lubbe Wiesner; Paolo Denti; Helen McIlleron; Gary Maartens; Graeme Meintjes
Journal:  Br J Clin Pharmacol       Date:  2020-02-17       Impact factor: 3.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.